The agreement demonstrates another vote of confidence from major drug companies in Millennium's hot biotech field: genomics, or mining databases of human genes for those that may be linked to diseases. The two companies plan to develop blood and tissue tests that will help doctors find the most effective existing treatments for melanoma,...